Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 9.6 USD -3.61%
Market Cap: 546.8m USD

Wall Street
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 11.99 USD with a low forecast of 7.07 USD and a high forecast of 15.75 USD.

Lowest
Price Target
7.07 USD
26% Downside
Average
Price Target
11.99 USD
25% Upside
Highest
Price Target
15.75 USD
64% Upside
Design Therapeutics Inc Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
24% Upside
PHIL
Philogen SpA
13% Upside
HALO
Halozyme Therapeutics Inc
13% Upside
ALNY
Alnylam Pharmaceuticals Inc
24% Upside
RLYB
Rallybio Corp
40% Upside
688177
Bio-Thera Solutions Ltd
54% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
ORY
Oryzon Genomics SA
130% Upside

Revenue
Forecast

Revenue Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSGN's stock price target?
Price Target
11.99 USD

According to Wall Street analysts, the average 1-year price target for DSGN is 11.99 USD with a low forecast of 7.07 USD and a high forecast of 15.75 USD.

Back to Top